Header Logo

Connection

Juleen Zierath to Enzyme Inhibitors

This is a "connection" page, showing publications Juleen Zierath has written about Enzyme Inhibitors.
Connection Strength

0.703
  1. Zierath JR. Kinases in diabetes. Part I. 11-12 November 2004, Manchester, UK. IDrugs. 2005 Feb; 8(2):118-20.
    View in: PubMed
    Score: 0.212
  2. Zierath JR. Kinases in diabetes. Part II. 11-12 November 2004, Manchester, UK. IDrugs. 2005 Feb; 8(2):121-3.
    View in: PubMed
    Score: 0.212
  3. Sardon Puig L, Pillon NJ, N?slund E, Krook A, Zierath JR. Influence of obesity, weight loss, and free fatty acids on skeletal muscle clock gene expression. Am J Physiol Endocrinol Metab. 2020 01 01; 318(1):E1-E10.
    View in: PubMed
    Score: 0.147
  4. Al-Khalili L, de Castro Barbosa T, Ostling J, Massart J, Cuesta PG, Osler ME, Katayama M, Nystr?m AC, Oscarsson J, Zierath JR. Proteasome inhibition in skeletal muscle cells unmasks metabolic derangements in type 2 diabetes. Am J Physiol Cell Physiol. 2014 Nov 01; 307(9):C774-87.
    View in: PubMed
    Score: 0.103
  5. Benziane B, Bj?rnholm M, Lantier L, Viollet B, Zierath JR, Chibalin AV. AMP-activated protein kinase activator A-769662 is an inhibitor of the Na(+)-K(+)-ATPase. Am J Physiol Cell Physiol. 2009 Dec; 297(6):C1554-66.
    View in: PubMed
    Score: 0.018
  6. Al-Khalili L, Chibalin AV, Yu M, Sj?din B, Nyl?n C, Zierath JR, Krook A. MEF2 activation in differentiated primary human skeletal muscle cultures requires coordinated involvement of parallel pathways. Am J Physiol Cell Physiol. 2004 Jun; 286(6):C1410-6.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.